RNA interference (RNAi), a post-transcriptional gene silencing mechanism originally described in Caenorhabditis elegans, involves sequence-specific mRNA degradation mediated by double-stranded RNAs (dsRNAs). Passive dsRNA uptake has been uniquely observed in C. elegans due to the expression of systemic RNA interference defective-1 (SID-1). Here we investigated the ability of ectopic SID-1 expression to enable passive cellular uptake of short interfering RNA (siRNA) or double stranded RNA (dsRNA) in pluripotent mouse embryonic stem cells (mESCs). When SID-1-GFP and the Firefly luciferase reporter gene (luc Fir ) were co-expressed in mESCs, luc Fir activity could be suppressed by simple incubation with dsRNAs/siRNAs that were designed to specifically target luc Fir . By contrast, suppression was not observed in mESCs expressing luc Fir and GFP alone or when either GFP-or SID-1-GFP-expressing cells were incubated with control dsRNAs/siRNAs (non-silencing or Renilla luciferase-specific). These results may lead to high-throughput experimental strategies for studying ESC differentiation and novel approaches to genetically inhibit or eliminate the tumorigenicity of ESCs.
RNA interference (RNAi), a post-transcriptional gene silencing mechanism originally described in Caenorhabditis elegans and plants, involves sequence-specific degradation of homologous messenger RNA (mRNA) mediated by double-stranded RNA (dsRNA) molecules [1] . Upon entering cells, dsRNAs are cleaved by the conserved Dicer family of RNase III enzymes to produce short interfering RNAs (siRNAs) that are typically 21-23 nucleotides in length. siRNAs are then incorporated into the RNAinduced silencing complex (RISC) where the unzipped, antisense strand of the siRNA binds a complimentary sequence and subsequently cleaves the target mRNA resulting in gene-specific silencing [2, 3] . Although dsRNAs typically enter cells by natural viral infections (which in turn can lead to interferon responses in certain mammalian cell types) or other exogenous means, systemic dsRNA uptake has been uniquely observed in C. elegans [4] due to expression of systemic RNA interference defective-1 (SID-1), a 776-amino acid transmembrane channel protein [5, 6] . Interestingly, ectopic expression of the C. elegans protein SID-1 in Drosophila cells enables passive cellular uptake of dsRNA or siRNA via direct soaking [5] .
Although conventional methods such as injection, transient transfection (e.g. cationic lipid-based transfec-tion reagents), electroporation and recombinant virusmediated delivery of short hairpin RNA (shRNAs) are effective for inducing RNAi in mammalian cells, these approaches often require the generation and testing of multiple constructs, which can be labor-intensive. Here we investigated the ability of ectopic SID-1 expression to confer systemic dsRNA or siRNA uptake in pluripotent mouse embryonic stem cells (mESCs). Our experiments show that the simple incubation of SID-1-expressing mESCs in media containing dsRNAs or siRNAs is sufficient to cause gene-specific RNAi. These results may facilitate high-throughput silencing of multiple genes in future experiments as well as potential therapeutic applications.
Materials and methods
Cell culture. Human embryonic kidney 293T (HEK) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL; Carlsbad, CA) supplemented with 10% fetal bovine serum (Gibco-BRL), 2 mM L-glutamine, 0.1 mM nonessential amino acids and 500 lg/mL geneticin (Invitrogen; Carlsbad, CA).
For mESCs, the mouse ES-D3 line (ATCC; Manassas, VA) was used. Pluripotency was maintained by growing mESCs on an irradiated MEF feeder layer with 1000 U/ml leukemia inhibitory factor (LIF) (Chemicon; Temecula, CA) as we recently described [7] .
Ectopic SID-1 expression. For transgene delivery, we employed the same lentiviral vector [8] that we previously used for modifying human ESCs [7, 9, 10] . Briefly, the SID-1 transgene from pPACPl-SID-1::FLAG (a kind gift from Dr. Craig P. Hunter, Harvard University) was subcloned into pLV-CAG-GFP to generate pLV-CAG-SID-1-GFP, which directs the expression of the fusion protein SID-1-GFP under the control of CAG, an internal composite constitutive promoter containing the CMV enhancer and the b-actin promoter. Recombinant lentiviruses (LV) were generated using the 3-plasmid system [11] by co-transfecting HEK cells with pLV-CAG-GFP or pLV-CAG-SID-1-GFP, pMD.G and pCMVDR8.91. For each 100-mm dish of HEK cells plated at 80-85% confluency, 5, 2.5, and 10 lg of pLV, pMD.G and pCMVDR8.91 DNA were used for transfection, respectively. LVs were harvested by collecting the culture medium at 24 and 48 h post-transfection. LVs generated using this protocol typically had titers in the range of 1 · 10 6 to 6 · 10 6 TU/mL, and were stored at À80°C before use. For transduction, purified LVs were added to cells at a final concentration of 10,000 TU/mL with 6 lg/mL polybrene. The multiplicity of infection (MOI) was $5. Fir have been described [5] , and those for luc Ren are provided in Table 1 . All primers were purchased from Invitrogen.
For siRNA (Qiagen Inc.; Valencia, CA), the sense and antisense sequences were CUUACGCUGAGUACUUCGATT and UCGAAGU ACUCAGCGUAAGTT for luc Fir -siRNA, and UUCUCCGAAC GUGUCACGUTT and ACGUGACACGUUCGGAGAATT for control (non-silencing) siRNA. All dsRNAs and siRNAs sequences were BLAST searched to ensure no sequence similarity to any known mammalian genes.
Transfection. Transfection was performed using Lipofectamine 2000 (Gibco-BRL) according to the manufacturer's protocol. Transfected cells were incubated at 37°C for 24 h for protein expression before luc Fir activity was assessed.
Flow cytometry. Flow cytometry analysis was performed on a FACSCalibur instrument (BD Pharmingen; San Diego, CA) and analyzed using FlowJo software (Tree Star, San Carlos, CA). For assessing apoptosis, Annexin V-Phycoerythrin (Annexin V-PE) and 7-Aminoactinomycin (7-AAD) were employed (BD Pharmingen). Briefly, cells were washed with cold PBS, resuspended in Annexin V-binding buffer (BD Pharmingen) at a concentration of 1 · 10 6 cells/mL, followed by incubating with 5 lL of Anexin V-PE and 7-AAD for 15 min at room temperature in the dark prior to flow cytometry analysis. For fluorescence-activated cell sorting (FACS), FACS Vantage instrument (BD Pharmingen) was used.
Western blot. Cells were harvested in a lysis buffer containing 20 mM Hepes (pH 7.4), 2 mM EGTA, 50 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 5 mM NaF, 1% Triton X-100, 10% glycerol, 2 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 2 lg of leupeptin/ml, and 2 lg of aprotinin/ml, vortexed, and centrifuged at 25,000g for 15 min. Whole-cell protein aliquots (30 lg) were size-fractionated by SDS-PAGE and transferred to nitrocellulose membranes (Schleicher & Schuell; Keene, NH). Protein signals were detected using Western Lightning Chemiluminescence Reagent Plus (Perkin-Elmer Life Sciences; Boston, MA).
Luciferase assay. 4 · 10 4 cells per well were plated on a solid black 96-well plate (Corning). Luciferase activity was measured using the SteadyGlo luciferase assay system (Promega; Madison, WI) on a microplate reader.
Statistical analysis. All data reported are means ± SEM. Statistical analysis was performed using one-way ANOVA and Tukey's HSD post hoc test with p < 0.05 being considered as statistically significant. 
Results
Generation of a human cell line that stably expresses SID-1-GFP HEK 293T cells were transduced with LV-CAG-SID-1-GFP (Fig. 1A) and upon initial transduction, yielded $ 30% GFP-positive cells (vs. 0% for non-transduced control cells; Fig. 1B) . Cells expressing the highest GFP signal (8.23% of the original population) were FACS-sorted, followed by culturing for recovery. Recovered, stably LV-CAG-SID-1-GFP-transduced HEK 293T cells displayed normal morphology (Fig. 1C) , remained green for >4 months (longer periods were not monitored) while proliferating indistinguishably from non-transduced control cells (data not shown). Furthermore, GFP epifluorescence was limited to the membrane surface, consistent with the notion that SID-1 is a transmembrane protein [5] . Western blot analysis of stably LV-CAG-SID-1-GFP-transduced HEK 293T cells with a monoclonal antibody against GFP generated a detectable band at $116 kDa consistent with the expected size of SID-1-GFP (Fig. 1D) . Transient pLV-CAG-SID-1-GFP transfection of HEK 293T cells yielded a similar result.
dsRNA-and siRNA-induced luciferase suppression was sequence-specific
We next verified the efficacy of our siRNA and dsRNA constructs to induce gene-specific RNAi by assessing their ability to suppress the transiently expressed reporter luc Fir activity. Fig. 2A LV-CAG-SID-1-GFP-transduced cells uniquely enabled passive entry of soaking dsRNAs/siRNAs and subsequent gene-specific RNAi
To investigate whether SID-1 overexpression enables passive dsRNA/siRNA entry into mammalian cells, control (non-transduced) and LV-SID-1-GFP-transduced HEK 293T cells were transfected with pGL3-luc Fir , followed by simple soaking with dsRNAs (Fig. 2B) Ren -dsRNA or non-silencing siRNA, suggesting that the SID-1-mediated RNAi effects observed were sequence and gene-specific.
Functional consequences of SID-1 overexpression in mouse embryonic stem cells
To explore the use of SID-1 to confer the ability to passively uptake dsRNA/siRNA on pluripotent mESCs so that gene-specific RNAi can be induced by simple soaking, we co-expressed luc Fir and either GFP or SID-1-GFP in mESCs (Figs. 3A and B) . Similar to our HEK 293T cell experiments, only GFP-positive mESCs were FACS-sorted for experiments (Figs. 3C and D) . As anticipated, GFP signals were found throughout the cytoplasm of GFP-expressing mESCs; by contrast, epifluorescence was limited to the membrane surface for mESCs expressing the fusion protein SID-1-GFP. Fig. 3C shows that soaking SID-1-GFP-but not GFPexpressing mESCs in luc Fir -dsRNA significantly suppressed luc Fir activity: 30 lg/mL and 100 lg/mL 100 bp Fir activity of SID-1-GFP-expressing mESCs to 58.3 ± 5.4%, 45.4 ± 3.5%, respectively, (p < 0.05). By contrast, no suppression was observed for soaking SID-1-GFP-expressing mESCs 1) without any luc Fir -dsRNA or 2) with 100 bp luc RendsRNA. In addition, control GFP-expressing cells soaked in luc Fir -dsRNA also showed no change in luc Fir reporter activity, suggesting that the RNAi-suppressed luc Fir activity observed was SID-1-mediated and sequence-specific. Examination for apoptosis and cell viability by Annexin V-PE and 7-AAD staining revealed no significant differences between GFP-and SID-1-GFP-expressing mESCs (Fig. 3D) .
Discussion
SID-1, originally identified in C. elegans, belongs to a novel, uncharacterized gene family that is also present in mammals [5, 6] . Although the structure-function properties are as yet unknown, a recent report demonstrates that overexpression of a human SID-1 homolog in pancreatic ductal adenocarcinoma cells enhances the passive uptake of siRNAs [12] . The expression levels of the mammalian homologues have not been determined, but our present results indicate that the endogenous activity is insignificant in HEK 293T and mESCs because their incubation with dsRNAs or siRNAs alone did not suppress the targeted gene unless SID-1 was also expressed. The lack of detectable endogenous activity might be due to the presence of non-functional SID-1 homologues. Alternatively, it is possible that functional SID-1 homologues are simply not expressed in the cell types investigated. Our present experiments do not allow us to distinguish between these possibilities. Nonetheless, we have demonstrated that ectopic SID-1 expression in HEK and mES cells enables passive uptake of dsRNAs and siRNAs, which in turn can suppress sequence-specific targets without detrimental effects, at least over the time course of our experiments where parameters such as proliferation rate, morphology and apoptosis, were assessed.
The accumulation of long dsRNAs (>30 bp), commonly present in numerous viral life cycles, in certain mammalian cells can lead to an immune response and the induction interferon. This subsequently blocks protein translation in a non-specific manner via protein kinase-dependent inactivation of elongation factors, and ultimately leads to apoptosis [4, [13] [14] [15] . Indeed, the non-specificity of such interferon-meditated effects, which can mask the specific RNAi of interest, has been a major limitation for many RNAi experiments in mammalian cells [16] [17] [18] [19] [20] . In contrast, long dsRNA duplexes can efficiently induce specific RNAi in organisms or systems that lack interferon responses [1, 4, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] . For instance, long dsRNA (typically $500-1500 bp) can readily induce gene-specific silencing in oocytes [28] , preimplantation embryos [27, 32] , embryonal teratocarcinoma cells [25] , and ESCs [26, 33] . Taken collectively, our observations of gene-specific RNAi with SID-1-expressing mESCs are consistent with the refractoriness of interferons in undifferentiated mESCs to induction [26, 33] .
In addition to their promising therapeutic potential, ESCs are also useful models for studying pluripotency, self-renewal and differentiation. Indeed, a better understanding of these important properties and processes of ESCs is critical for the development of ESC-based therapies. Loss-of-function studies have been proven to shed functional and mechanistic insights into various important developmental and differentiation processes. However, high-throughput genomic screening is largely limited by tedious experimental procedures (e.g. homologous recombination to knock-out a specific gene) and gene-specific RNAi may be an alternative for applicable cell types. Transfection or transduction (for transfection-resistant cells such as human ESCs [9, 10] and other terminallydifferentiated cells such as neurons and cardiomyocytes) is commonly exploited to introduce dsRNAs/siRNAs/ shRNAs into cells. However, unless delivery vehicles such as LVs and adeno-associated viruses are employed, the resultant RNAi activity is often transient and short-lived. Our present results suggest that SID-1-expressing ESCs may conveniently enable high-throughput silencing of multiple genes for studying ESC differentiation. The ability to suppress genes specifically may also lead to the development of novel strategies to inhibit or eliminate the oncogenic potential of ESC for therapeutic applications (e.g. suppression of such gene products as ion channels that modulate cell proliferation [7, 9, 10] ).
Although conceptually attractive, a number of hurdles need to be overcome before SID-1 or its homologues can be broadly applied for high-throughput silencing in ESCs. For instance, we attempted but were unable to establish mouse and human ESC lines that stably expressed SID-1-GFP. Although mESCs could be readily transiently transfected with SID-1-GFP without apparent ill effects (when apoptosis and cell viability were assessed) during the time course of our experiments (i.e. 48-72 h), stable transduction of either human or mouse ESCs with LV-SID-1-GFP led to cell death typically 4-5 days after the GFP signals initially appeared. Given such short time windows, we were unable to reproducibly and statistically suppress endogenous gene expression such as that of b-integrin (as assayed by quantitative RT-PCR) via SID-1-mediated dsRNA uptake. The basis of this time-dependent cytotoxic effect of SID-1 on ESCs is not known. Perhaps, human and mouse ESCs would be more tolerant to ectopic expression of mammalian homologues of SID-1 (rather than from C. elegans). Alternatively, it is possible that constitutive expression of SID-1 per se is detrimental. If this is the case, inducible expression of SID-1 for a brief period for incubation with dsRNA or siRNAs can be a potential solution but such conditional gene expression systems for human ESCs have not yet been described.
Hunter and colleagues (2003) reported that longer the dsRNAs, the better their SID-1-mediated uptake [5] . Thus, we have also investigated the effect of 500 bp luc Fir -dsRNAs (Primer sequences for luc Fir from [5] and luc Ren shown in Table 1 ) in addition to the 100 bp constructs reported here. Although some suppressive effect was also observed when SID-1-GFP expressing HEK 293T and mESC were incubated in media containing 30 lg/ml 500 bp dsRNA targeting Luc Fir , a dose-dependent response similar to that of our 100 bp luc Fir -dsRNAs was not observed. Furthermore, higher concentrations led to nonspecific suppression. The reason for this non-specific effect at higher concentrations is not known, but was observed when using dsRNAs targeting either luc Fir or luc Ren . A better understanding of the basic biology (e.g. structure-function properties) of SID-1 will be crucial for overcoming the above mentioned limitations. Nevertheless, our present results shed insights into the development of high-throughput experimental strategies for studying ESC differentiation.
